r The action potential initiation in the nerve terminals and its subsequent conduction along the axons of afferent nerves are not necessarily dependent on the same voltage-gated sodium channel (Na V 1) subunits.
Introduction
Activation of sensory nerves involves the transduction of a stimulus (physical or chemical) to a membrane depolarization referred to as the 'generator potential' or 'receptor potential' . If the generator potential is of sufficient rate and magnitude, it activates voltage-gated sodium channels (Na V 1s). This step is absolutely required for the genesis of action potentials (APs) and their conduction along the axon to the central terminals in CNS, where it evokes the release of neurotransmitters at the synapse on secondary neurons (Hodgkin & Huxley, 1952) . Among the nine subtypes of the pore-forming α subunit of Na V 1 channels, Na V 1.1, 1.2, 1.3, 1.6, 1.7, 1.8 and 1.9 are commonly expressed in neurons, with differing nerve phenotypes expressing distinct subsets of Na V 1 channels (Catterall, 2012; Schild & Kunze, 2012) . TTX potently blocks all of these channels, except Na V 1.8 and Na V 1.9. Although it is known that Na V 1s are essential for the genesis and conduction of APs, it is not necessarily the case that these two processes depend equally on the same subtypes of Na V 1s. With respect to nociceptive C-fibres in the cornea, for example, it has been shown that the genesis of APs at the nerve terminals within the tissue can occur independently of TTX-sensitive Na V 1s, whereas the conduction of the APs in the trigeminal nerve is blocked with TTX (Brock et al. 1998) .
The sensory nerves innervating the respiratory tract are primarily derived from neurons in vagal sensory ganglia (Mazzone & Undem, 2016) . The majority of respiratory vagal afferent nerves are C-fibres that have nociceptive characteristics. Activation of these nerves can evoke parasympathetic reflex bronchospasm and secretions, as well as sensations of urge-to-cough and dyspnoea. Two phenotypically distinct types of vagal C-fibre nociceptors innervate the guinea pig respiratory tract in approximately equal numbers, namely the epibranchial placode-derived nodose C-fibres and neural crest-derived jugular C-fibres. Another type of nociceptor that innervates the extrapulmonary airways of guinea pigs is the nodose Aδ-fibre . Stimulation of nodose Aδ-fibres evokes the cough reflex even in anaesthetized animals and they have been therefore referred to as cough receptors (Canning et al. 2004) . Stimulation of vagal C-fibres in the guinea pig airways can also lead to cough, although only in conscious animals.
In acute and chronic inflammatory airways diseases, it is assumed that vagal nociceptors can become overstimulated, leading to a hyper-reflexic state that can result in bronchospasms, hypersecretions and coughing exceeding their otherwise utilitarian function (Lee & Yu, 2014) . If this is the case, quelling the activity of airway nociceptors would be a rational therapeutic strategy.
We have previously determined that vagal sensory neurons express primarily Na V 1.7, 1.8 and 1.9 mRNA (Kwong et al. 2008) . We also determined that, when Na V 1.7 was selectively silenced using adeno-associated virus-short hairpin RNA (AAV-shRNA) technology, the conduction of APs along the vagal fibres was largely inhibited (Muroi et al. 2011) . Animals treated with Na V 1.7 shRNA lose both the C-fibre derived conscious cough, as well as the nodose Aδ-fibres driven reflex unconscious cough (Muroi et al. 2011 (Muroi et al. , 2013 .
The shRNA strategy to decrease Na V 1.7 expression is predicted to diminish the density of Na V 1.7 channels in the membranes of the afferent neuron cell body, along the conducing axons, as well as at the peripheral and central nerve terminals. The question remains how effective is blocking of Na V 1.7 selectively at the fibre/terminals within the airway tissue in inhibiting AP genesis. This question is critical inasmuch as a topical administration of therapeutic drugs (such as Na V 1.7 blockers) to the airways by inhalation is a feasible and preferred route minimizing the systemic side effects. In the present study, we address this key issue by taking advantage of recently discovered selective Na V 1 inhibitors combined with isolated innervated airways preparations that allow for the delivery of inhibitors selectively to the nerve ending-components within the tissue vs. to the conducting fibres in the vagus nerves.
Methods

Ethical approval
The experiments were approved by the Johns Hopkins School of Medicine Animal Care and Use Committee. The investigators understand the ethical principles under which The Journal of Physiology operates and their work complies with the animal ethics checklist as described by Grundy (Grundy, 2015) . Male Hartley guinea pigs were obtained (Hilltop Laboratory Animals Inc., Scottsdale, PA, USA) weighing 100-200 g. The animals were housed in an approved animal facility under a 12:12 h light/dark cycle with controlled temperature and humidity, in groups in cages providing unrestricted access to food and water and an appropriate environmental enrichment. The animals were I.P. injected with anti-coagulant heparin (2000 IU kg −1 ; diluted in saline 1000 IU ml −1 ). Heparin prevents blood clot formation and was used to improve blood removal from the pulmonary circulation. After 20 min, the animals were killed by exposure to CO 2 in a rising concentration and exsanguination. CO 2 was sourced form compressed CO 2 gas cylinder and administered at a flow rate measured by flow meter displacing ß20-30% of the chamber volume per minute conforming to (Grundy, 2015) . The isolated preparations were studied at 37°C in Krebs bicarbonate solution (KBS); composed of (mM): 118 NaCl, 5.4 KCl, 1.0 NaH 2 PO 4 , 1.2 MgSO 4 , 1.9 CaCl 2 , 25.0 NaHCO 3 and 11.1 dextrose, gassed with 95%O 2 -5%CO 2 (pH 7.4).
Tracheal tube preparation
A modification of the isolated vagally innervated tracheal preparation described previously (Riccio et al. 1996b ) was used for extracellular recording of AP from nodose and jugular vagal afferent nerve fibres that have defined receptive fields in the tracheal wall (Fig. 3A) . The trachea with intact right-side extrinsic vagal innervation (including vagus nerve, superior laryngeal nerve, recurrent laryngeal nerve and nodose and jugular ganglia) was removed and placed in a dissecting dish containing KBS. Connective tissue was trimmed away, leaving the trachea, larynx with intact nerves. The rostral and caudal end of the tracheal tube was cannulated and the trachea was perfused (inside) with KBS (37°C) at a rate of 6-8 mL min -1 . Simultaneously, the tissue was also separately superfused (from outside) with KBS (6-8 mL min -1 at 37°C). The drugs were applied to the receptive field via the perfusion buffer in a rostral-caudal direction before stimulation the preparation. With this design, any drug that could leak through the trachea would be immediately diluted by the superfusion KBS (Fig. 1) . This allows for the drugs to be selectively applied to the tissue containing receptive fields inside the trachea but not reaching vagus nerve and laryngeal nerves containing conducting axons. The right nodose and jugular ganglia, along with the rostral most vagus and superior laryngeal nerves, were gently pulled through a small hole into an adjacent compartment and separately superfused with KBS (6-8 mL min -1 at 37°C) for recording of single fibre activity as described previously.
Trachea lung preparation
The perfused vagal innervated tracheal-lung preparation was set up as described previously (Fig. 4A) . After isolating the lungs, perfusion with KBS was used to wash the blood from the pulmonary circulation. The trachea and right lungs with intact right-side extrinsic vagal innervation including right jugular and nodose ganglia were dissected and placed in a two-compartment tissue bath. The right nodose and jugular ganglia along with the vagus nerve were placed in one compartment, with the lung and trachea in the second compartment. The two compartments were separately superfused with KBS (6 mL min -1 at 37°C) containing indomethacin (3 μM). Indomethacin reduces the indirect influence of tissue prostanoids on C-fibre activation. The pulmonary artery and trachea were cannulated with PE tubing and continuously perfused with KBS (4 and mL min -1 , respectively). Drugs were added to the receptive field of the nerve via both the artery and trachea. The drugs in the perfusing buffer solution therefore exit the lungs via both these puncture ports, as well as via the pulmonary veins, and were immediately diluted into the superfusion buffer.
The single nerve activity was recorded with glass microelectrodes pulled with micropipette puller model P-87 (Sutter Instrument Company, Novato, CA, USA) and filled with 3 M sodium chloride (resistance ß 2 M ). The signal was amplified (Microelectrode AC amplifier 1800; A-M systems, Everett, WA, USA), filtered (low cut off, 0.3 kHz; high cut-off, 1 kHz), displayed on an oscilloscope (TDS 340; Tektronix, Beaverton, OR, USA) and a chart recorder (TA240) and recorded (sampling frequency 33 kHz) onto a computer for offline analysis (TheNerveOflt; PHOCIS, Baltimore, MD, USA).
Recording electrode manipulation into either the nodose or jugular ganglion
A mechanosensitive receptive field was identified when a mechanical stimulus (Von Frey hair, 1800-3000 mN) (Mazzone & Undem, 2016) . C, putative nerve terminals of nodose Aδ-fibres and jugular C-fibres are located close to tracheal lumen. Putative nodose Aδ-fibre is visualized by staining for α 3 subunit NaK-ATPase (red, denoted by asterisk) and putative jugular C-fibres are visualized by staining for substance P (green, indicated by arrowheads). Confocal image of a thin cross-section of the guinea pig trachea, adopted from (Mazzone et al. 2009 bluntly applied to the lung surface evoked a burst of APs. Once a mechanosensitive receptive field was identified, a brief (<1 ms) electrical stimulus was delivered by a small concentric electrode positioned over this discrete mechanosensitive region to determine the conduction velocity of the fibre. The receptive field was stimulated electrically with a square pulse (0.5 ms) of increasing voltage (starting at 5 V) until an AP was evoked. Conduction velocity was calculated by dividing the distance along the nerve pathway by the time between the shock artefact and the AP evoked by electrical stimulation of the mechanosensitive receptive field. On those rare occasions where two units were recorded simultaneously, wave analysis software (TheNerveOflt; PHOCIS) was used to distinguish between the two peaks. This method has been described previously ).
Action potential conduction in vagal axons
A modification of the isolated vagally-innervated tracheal preparation described previously (Riccio et al. 1996b) was used. As shown in Fig. 5A , the vagus nerve was routed through an additional chamber that was isolated by vaseline from both the recording chamber (containing vagal ganglia with the cell bodies of sensory neurons) and the tissue chamber (containing the trachea with receptive fields). Therefore, the access of drugs applied in the superfusion in this chamber was limited to the vagus nerve. The segment of the vagus nerve in the chamber was carefully desheathed. The receptive filed in trachea was stimulated by application of citric acid (Kollarik & Undem, 2002) .
Single cell RT-PCR of airway specific vagal neurons
The neurons innervating the trachea were retrogradely labelled using retrograde tracer DiI (Invitrogen, Carlsbad, CA, USA) in solution (1% in DMSO diluted 1:10 in PBS). Guinea pigs were anaesthetized by injection of ketamine (50 mg mL -1 ) and xylazine (2.5 mg mL -1 ). Using sterile surgical approach cervical trachea was exposed through the midline 5 mm cervical skin incision, the needle connected to Hamilton syringe was inserted into the tracheal lumen by penetrating the anterior tracheal wall and the dye was injected into two sites (5-10 μL per site) in the dorsal tracheal wall. Subcutaneus layers and the skin were sutured. Following the surgery, animals recovered on a heated pad under close observation for 2-3 h. The animals were monitored for wound healing and the presence of distress and pain daily. No animal in the present study met conditions under which early death would be considered as defined in our animal protocol. Then, 14-21 days after injection, the animals were killed by CO 2 asphyxiation and exsanguination. Jugular and nodose ganglia were harvested, enzymatically dissociated (collagenase 2 mg mL -1 and dispase II 2 mg mL -1 dissolved in Ca-, Mg-free Hanks' balanced salt solution) at the same time as repeatedly being triturated with a glass fire-polished Pasteur pipettes, then washed by centrifugation and suspended in L-15 medium containing 10% FBS. The cell suspension was transferred onto poly-D-lysine/laminin-coated coverslips. After the suspended neurons had adhered to the coverslips for 2 h (37°C), the neuron-attached coverslips were flooded with the L-15 medium (10% FBS). Coverslips with dissociated neurons were constantly perfused by PBS. The DiI-labelled cells were identified using fluorescence microscopy and labelled single neurons were collected into a glass pipette (tip diameter 50-150 μm, pulled with a micropipette puller P-87; Sutter Instrument Company) by applying negative pressure within. The pipette tip was then broken in a PCR tube containing 1 μL of resuspension buffer (from SuperScript III CellsDirect as described below; Thermo Fisher Scientific Inc., Waltham, MA, USA) and RNAse inhibitor (RNaseOUT; 2 U μL -1 ). The tubes were immediately snap frozen and stored on dry ice. Only one to four cells were collected from each coverslip.
The major concern in this type of experiments is whether the sample that also contains some superfusing fluid is contaminated by RNA/DNA from adjacent and/or damaged/lysed cells. To control this problem, we collected only the neurons that were clean and not attached to other neurons, other cells or debris. In addition, our approach using constant flow perfusion of the coverslips during the cell collection was repeatedly confirmed to be effective for essentially eliminating any contamination. In each experiment, the samples of superfusing fluid from the vicinity of the collected neurons was obtained. These negative controls were found to be almost uniformly negative (in two instances when positive, all cells from the experiment were discarded).
For single-cell RT-PCR, first-strand cDNA was synthesized from single neurons using the SuperScript(tm) III CellsDirect cDNA Synthesis System (Thermo Fisher Scientific Inc.) in accordance with the manufacturer's instructions. Samples were defrosted, lysed (10 min, 75°C) and treated with DNAse I. Then, poly(dT) and random hexamer primers (Roche Applied Science, Madison, WI, USA) were added. The samples were reverse transcribed by adding SuperscriptIII RT for cDNA synthesis. Then, 2 μL of each sample (cDNA, water control or bath control) was used for PCR amplification with the HotStar Taq Poymerase Kit (Qiagen, Valencia, CA, USA) in accordance with the manufacturer's instructions in a final volume of 20 μL. After an initial activation step 95°C for 15 min, cDNAs were amplified with custom-synthesized primers (Life Technologies, Grand Island, NY, USA) by 50 cycles of denaturation at 94°C for 30s, annealing 60°C for 30s and extension 72°C for 1 min, followed by a final extension 72°C for 10 min. Products were visualized in ethidum-bromide stained 1.5% agarose gels with 50 or 100 bp DNA ladder. Images were prepared using PowerPoint (Microsoft Corp., Redmond, WA, USA) and Preview (Apple Inc., Cupertino, USA). Intron-spanning primers specific for each guinea pig Na V 1 α subunit were designed based on indicated Pubmed sequences with the aid of the UCSC (University of California, Santa Cruz, CA, USA) Genome Browser using Primer3, version 0.4.0 (Rozen & Skaletsky, 2000) (Table 1) . These primers were reported previously (Kocmalova et al. 2017) . For most primers, no genomic product can be amplified because its predicted size >1000 bp is not achievable with the extension time of 30s used for PCR. The selectivity of each primer was evaluated by aligning all Na V 1 subunits with each primer using ClustalW (https://www.ebi.ac.uk/Tools/msa/clustalw2/). RNA for positive control was selected based on established Na V 1 subunit expression pattern: whole brain RNA for Na V 1.1, 1.2, 1.3 and 1.6; skeletal muscle RNA for Na V 1.4; heart muscle RNA for Na V 1.5; and dorsal root ganglia (DRG) or vagal sensory ganglia RNA for Na V 1.7, 1.8 and 1.9. The guinea pig RNA was isolated using the RNAeasy mini kit (Qiagen).
Patch clamp electrophysiology
The jugular and nodose ganglia were dissected, cleared of adhering connective tissues, cut into a few pieces, respectively, and digested enzymatically using type 1A collagenase (2 mg mL -1 ) and dispase II (2 mg mL -1 ) as described previously (Kwong et al. 2010) . The isolated nodose and jugular neurons were kept separately at 37°C in L-15 medium containing 10% of FBS for use within 24 h.
A conventional whole-cell patch clamp technique was employed to record the sodium current (I Na ) using an Axopatch 200B amplifier interfaced with Axon Digidata 1550A and driven by pCLAMP 10 software (Molecular Devices, Sunnyvale, CA, USA). Bath solution contained (mM): 126 choline-Cl, 10 NaCl, 3 CsCl, 5 TEA-Cl, 0.1 CdCl 2 , 1 MgCl 2 , 1 CaCl 2 , 10 Hepes and 10 glucose with pH adjusted to 7.35 with CsOH. Pipette solution contained (mM): 140 CsF, 10 NaCl, 1 MgCl 2 , 0.1 CaCl 2 , 1.1. EGTA and 10 Hepes with pH adjusted to 7.2 with CsOH. Pipettes with a tip resistance ß1 M were used so that a lower access resistance (usually between 1.5 and 4 M ) could be obtained. Cell capacitance and series resistance were compensated electronically by ß80% to ensure an adequate voltage control. To record I Na , cells were held at -110 mV and depolarized every 5 s for 50 ms to voltages ranging from -90 to +20 mV at an increment of 5 mV. The current was sampled at 50 kHz and filtered at 10 kHz. Because pilot experiments showed a run-up of I Na and a negative shift of its voltage dependence following membrane rupture, the families of I Na in all cells were recorded 8-10 min after the whole-cell formation when the current become relatively stable. The J Physiol 596.8 steady-state inactivation of TTX-resistant I Na was studied using a conventional double-pulse protocol composed of conditioning pulses of 1 s from a holding potential of -110 mV to voltages from -90 to +10 mV followed by a test pulse to -20 mV.
An amphotericin B-perforated whole-cell patch clamp technique was used to record the membrane potentials under current clamp mode. APs were evoked by current pulses of 100 ms at an increment of 5 pA. Bath solution contained (mM): 136 NaCl, 5.4 KCl, 1 MgCl 2 , 1.5 CaCl 2 , 10 Hepes and 10 glucose with pH adjusted to 7.35 with NaOH. Pipette solution contained (mM): 20 KCl, 125 K-gluconate and 10 Hepes with pH adjusted to 7.2 with KOH. Freshly prepared amphotericin B was added to the pipette solution (300 μg mL −1 ) before the experiments. The junction potential (-14 mV estimated using the Clampex calculator (Molecular Devices)) was corrected offline for the readings of membrane potential. All patch clamp experiments were performed at room temperature.
Patch clamp data were analysed using Clampfit, version 10 (Molecular Devices) and SigmaPlot (Systat Software, Inc., San Jose, CA, USA). The amplitude of I Na was measured as the difference between peak currents and the steady-state current at the end of 50 ms pulses. The chord conductance of Na + channels (G Na ) was calculated using equation G Na = I Na /(V m -V rev ), where I Na is the current amplitude obtained at depolarizing voltages (V m ) and V rev is the reversal potential determined as the voltage where the fitted linear portion of the current-voltage (I-V) curve established in each cell intercepts with the zero-current voltage axis. The activation curve was established by plotting the G Na against V m and fitting the data to the Boltzmann function:
where G max is the maximal conductance, V 0.5 is the voltage for half-maximal activation and k is the slope factor. The steady-state inactivation curve was established by plotting the amplitude of I Na recorded at test pulse against the conditioning voltages (V m ) and fitting the data points to the Boltzmann function:
, where I max is the maximal current amplitude recorded at the test pulse following the most hyperpolarizing conditioning voltage, V 0.5 is the half-inactivation voltage and k is the slope factor. Pooled data are expressed as the mean ± SEM.
Guinea pig isolated trachea (tissue based Na V 1.7 assay)
We have previously reported that the parasympathetic nerve controlling cholinergic contractions of the guinea pig isolated trachea express Na V 1.7 as the only TTX-sensitive Na V 1 a subunit (Kocmalova et al. 2017) . Therefore, we can use this assay to assess the potency of selective Na V 1.7 drugs in an isolated tissue environment.
The trachea is isolated and set up in a standard tissue bath apparatus, the nerves are activated by electrical field stimulation and the cholinergic contractions are recorded exactly as described previously (Kocmalova et al. 2017) . The concentration response curve for PF-05089771 inhibiting the Na V 1.7-mediated responses was obtained in a cumulative fashion.
Statistical analysis
The single fibre recording data are presented as a total number of APs evoked by indicated stimuli and expressed as the mean ± SEM. The statistical tests used are indicated as appropriate.
Drugs and solutions
The compounds used were prepared as socks solutions stored at −20°C and were diluted in Krebs solution to their final concentrations on the day of use. The stock solutions of tetrodotoxin 1 mM (Alomone Laboratories, Jerusalem, Israel), bradykinin 10 mM (Sigma-Aldrich, St Louis MO, USA) and citric acid (Sigma-Aldrich) were dissolved in distilled water. Lidocaine (Sigma-Aldrich) 1 M was dissolved in ethanol. ICA121431, PF05089771 and PF01247324 (Tocris Minneapolis, MN, USA) and Compound 13 (first described in WO2012004706; Almirall Laboratories, Barcelona, Spain) were dissolved to 10 mM in DMSO.
Results
TTX blocks initiation of APs in nodose but not in jugular tracheal vagal nociceptors
The afferent innervation of the guinea pig trachea comprises nociceptive fibres derived from the jugular and nodose ganglia. The jugular ganglion-derived fibres are TRPV1 expressing capsaicin sensitive C-and Aδ-fibres. The nodose ganglion-derived fibres are mainly capsaicin-insensitive Aδ-fibres that are low threshold punctate mechanosensors and acid-sensors. The tracheal nodose Aδ-fibres are consistent with bona fide cough receptors (Canning et al. 2004) . Activation of both types of nociceptors can drive parasympathetic reflexes. An image of a C-fibre and an Aδ-fibre in a wholemount of the trachea is shown in Fig. 1A and B (Mazzone & Undem, 2016) . In previous studies evaluating the tracheal cross-sections, we noted that both the Aδ-fibres and the C-fibres terminate close to tracheal lumen (Fig. 1C) (Mazzone et al. 2009) , with the Aδ-fibres terminating beneath the epithelial basal membrane, whereas the C-fibres are found more superficial branching also above the basal membrane between the epithelial cells (Watanabe et al. 2005 (Watanabe et al. , 2006 Mazzone et al. 2009) . Figure 1 illustrates the diffusion path of drugs enabling access to nodose and jugular nerve fibre terminals in the tracheal lumen. Na V 1 α subunits mRNA expression. Single neuron RT-PCR of TRPV1-negative nodose neurons (presumed nodose Aδ-fibre neurons) and TRPV1-positive jugular neurons (presumed jugular C-fibre neurons) retrogradely labelled from the guinea pig trachea revealed that the Na V 1.7, Na V 1.8 and Na V 1.9 mRNA was the most frequently expressed (Fig. 2) . Although the expression of TTX-sensitive Na V 1.7 was similar between tracheal specific nodose TRPV1-negative and jugular TRPV1-positive neurons, the TTX-resistant Na V 1.8 and Na V 1.9 were more frequently expressed in jugular TRPV1-positive neurons (9/17 vs. 26/31, P < 0.05, Fisher's exact test; 8/17 vs. 26/31, P < 0.05, Fisher's exact test). Approximately 20% and 40% of tracheal specific nodose TRPV1-negative and jugular TRPV1-positive neurons, respectively, also expressed Na V 1.6. The other Na V 1 subunits were rarely expressed.
Action potential discharge. Tracheal jugular C-fibres fibres and nodose Aδ-fibres in the trachea are strongly and reproducibly activated by acid, although different ion channels are probably involved in the generator potentials (Kollarik & Undem, 2002) . When TTX (1 μM) was perfused through the lumen of the trachea for 30 min before citric acid application, the citric acid-induced burst of APs was abolished in six of six experiments with nodose Aδ fibres (Fig. 3B) . In two additional experiments, the number of citric-acid-induced APs was 81 and 47 before and 0 and 0 after treatment with 10 μM of the Na V 1.7 selective blocker Compound 13 (Kocmalova et al. 2017) . We have previously noted that Compound 13 is selective for Na V 1.7 and blocks guinea pig Na V 1.7-mediated parasympathetic responses in the guinea pig trachea with an IC 50 of ß0.5 μM and a maximal inhibitory effect at 10 μM (Kocmalova et al. 2017) .
By striking contrast to the nodose Aδ-fibres in the trachea, TTX had only a very modest effect on citric acid-induced AP discharge in the tracheal jugular C-fibres The expression of Na V 1 α subunits mRNA in putative tracheal nodose Aδ-fibre neurons (A) and jugular C-fibre neurons (B). Vagal nodose and jugular neurons were retrogradely labelled from the trachea. The putative nodose Aδ-fibre neurons were identified as labelled nodose neurons negative for TRPV1 mRNA (n = 17), whereas putative jugular C-fibre neurons were identified as labelled jugular neurons positive for TRPV1 mRNA (n = 31).
J Physiol 596.8 (Fig. 3C, n = 31) . In eight of these experiments, lidocaine was applied following TTX and this essentially abolished the response in all eight jugular C-fibres tested (Fig. 3C ) demonstrating the effective access of drugs applied into the lumen to nerve terminals. We also examined the effect of TTX on the electrical threshold of APs evoked by electrical stimulation of receptive fields of the jugular C-fibres in the trachea. TTX modestly but significantly increased the voltage required to evoke APs. The voltage threshold before and after TTX (1 μM) averaged 29 ± 2 V and 48 ± 8 V, respectively (n = 6, P < 0.05, paired t test). Adding lidocaine abolished the electrical response to 150 V (i.e. no AP was evoked by a maximum voltage output from stimulator) in five of these six C-fibres; in the remaining one C-fibre, lidocaine increased the threshold voltage to 90 V.
TTX blocks initiation of APs in nodose but not in jugular intrapulmonary vagal nociceptors
As discussed above, the nodose and jugular ganglia project two distinct subtypes of nociceptors into the trachea: nodose Aδ-fibres and jugular C-fibres. By contrast, both nodose and jugular nociceptors in the lungs are C-fibres . Although these nerves have unique activation profiles, and probably terminate in different areas in the CNS, both nodose and jugular C-fibres in the lungs are strongly and consistently activated by bradykinin and capsaicin ).
As we found in the nodose Aδ-fibres in the trachea, TTX (delivered selectively to the intrapulmonary compartment) abolished AP discharge in nodose C-fibres evoked by bradykinin (Fig. 4B) . Consistent with its marginal effect on the tracheal jugular C-fibres, TTX had no appreciable effect on the bradykinin-induced AP discharge in the jugular C-fibres terminating within the lungs (Fig. 4C) .
The blockade of the bradykinin-induced responses in nodose C-fibres by TTX was mimicked by two selective Na V 1.7 blockers: Compound 13 and PF-05089771 (Fig. 4B) . The concentration of PF-05089771 was chosen based on the concentration needed to abolish Na V 1.7-mediated parasympathetic responses in the guinea pig isolated trachea performed as described previously (Kocmalova et al. 2017) . We found that PF-05089771 blocked the Na V 1.7 responses in the guinea pig trachea with an IC 50 of 0.5 ± 0.2 μM and complete blockade at 3 μM (n = 4; data not shown). The concentrations of Na V 1.7 blockers Compound 13 and PF-05089771 required to inhibit the Na V 1.7-mediated response in native environment of nerve terminals with the airway was approximately more than ten-fold greater than that required to inhibit Na V 1.7 channels (in the inactivated state) in heterologous systems (Kocmalova et al. 2017) .
We addressed the hypothesis that Na V 1.8 supports the induction of TTX-resistant AP discharge in the jugular C-fibres. In patch clamp recordings at the cell soma, we found that the Na V 1.8 blocker PF-01247324 (Payne et al. 2015) effectively (but not potently) inhibited the fast TTX-resistant current in guinea pig vagal sensory neurons (Fig. 4D) . At 10 μM PF-01247324, the TTX-resistant current was inhibited by ß75% (Fig. 4D) . In nerve-lung preparation experiments, the bradykinin-induced AP A, photograph and a schematic drawing of the experimental set-up used for selective delivery of drugs to the tracheal lumen. B, TTX 1 μm applied to tracheal lumen (30 min) completely abolished citric acid (1 mM)-induced AP discharge in nodose Aδ-fibres (n = 6) ( * P < 0.05, paired t test). C, TTX 1 μM only marginally inhibited citric acid (1 mM)-induced AP discharge in jugular C-fibres (n = 31) ( * P < 0.05, paired t test). Adding lidocaine 1 mM completely abolished this response in all jugular C-fibres tested (n = 8) ( * * P < 0.01, paired t test). [Colour figure can be viewed at wileyonlinelibrary.com] discharge in 11 jugular C-fibres was reduced by ß50% in the presence of the Na V 1.8 blocker PF-01247324 10 μM (Fig. 4C) . When TTX 1 μM was combined with PF-01247324 10 μM, the response was almost abolished (Fig. 4C) .
TTX blocks conduction of APs in both nodose and jugular vagal nociceptors
Although TTX had no appreciable effect on AP initiation in jugular C-fibres within the trachea or lungs, it effectively blocked the conduction of AP in the majority of jugular C-fibres in the vagus nerve. In these experiments, a segment of vagus nerve was desheathed and TTX was applied to the vagus nerve outside the trachea either in superfusion or in a separate chamber and APs were evoked by citric acid applied to the tracheal lumen ( Fig. 5A and B) . TTX 1 μM abolished the AP discharge in six of eight jugular C-fibres tested. The number of citric acid-induced APs was 57 ± 14 and 0 ± 0 before and after TTX. In one of two remaining jugular C-fibres that were not abolished by TTX 1 μM applied to vagus nerve, TTX reduced the response by ß50% (from 91 to 47 APs) and adding PF-01247324 10 μM to TTX completely abolished the response (0 APs). 
blockers on intrapulmonary nociceptors
A, photograph and schematic drawing of the experimental set-up used for selective delivery of drugs to the lung. B, TTX 1 μm applied for 30 min into the lungs via airways and right pulmonary artery abolished bradykinin-induced AP discharge in nodose C-fibres (n = 6). The Na V 1.7 selective blockers Compound 13 and PF-05089771 had a similar effect (combined data are shown) (Compound 13 10 μM inhibited the response by 100 ± 0%, n = 3; PF-05089771 3 μM by 96 ± 4%, n = 4). C, TTX 1 μM alone had only an insignificant effect on bradykinin-induced AP discharge in jugular C-fibres (n = 9); however, the response to bradykinin was by 50% inhibited by Na V 1.8 blocker PF-01247324 10 μM (n = 11) ( * P < 0.05, paired t test) and >80% inhibited by combination of PF-01247324 10 μM and TTX 1 μM (n = 7) ( * P < 0.05, paired t test). D, evaluation of the efficacy of PF-01247324 10 μM to inhibit TTX-resistant I Na in jugular neurons. [Colour figure can be viewed at wileyonlinelibrary.com] J Physiol 596.8
In the other jugular C-fibre, TTX alone or together with PF-01247324 failed to inhibit AP conduction; however, it was completely abolished by lidocaine 1 mM. In another set of experiments, APs in jugular C-fibres were evoked by electrical stimulation (1 Hz) of the recurrent laryngeal nerve, which caries jugular C-fibres that mostly terminate in the trachea or esophagus. TTX 1 μM applied to the desheathed vagus nerve abolished electrically-induced APs in six of nine jugular C-fibres. The AP discharge frequency was reduced form 1 ± 0 Hz to 0 ± 0 Hz. Therefore, combined data from these two sets of experiments show that TTX 1 μM applied to desheathed vagus nerve completely blocked AP conduction in 70% (12/17) vagal jugular C-fibres (Fig. 5C) .
We have previously found that TTX or a selective knockdown of Na V 1.7 gene expression in the nodose ganglion blocks AP conduction in vagal nodose fibres (Muroi et al. 2011) . Here, we recorded APs in nodose Aδ-fibres innervating trachea evoked by electrical stimulation of their receptive field. We found that, in all tested fibres, the AP conduction was abolished by the Na V 1.7 selective inhibitor Compound 13 1-10 μM (Kocmalova et al. 2017 ) when applied to the desheathed vagus nerve (n = 3). Figure 6A shows representative recordings of I Na from a nodose and a jugular neuron in the absence and presence of 1 μm TTX. Digital subtraction of currents recorded in the presence of TTX (TTX-resistant, TTX-R) from those in the absence of TTX gave the TTX-sensitive I Na (TTX-S).
Patch clamp electrophysiology
In both nodose and jugular neurons, TTX eliminated a fast activated and deactivated current component and unveiled the slower activated and deactivated TTX-R. Mean I-V curves of TTX-S and TTX-R I Na for nodose and jugular neurons are plotted in Figure 6B . The voltage-dependent properties of the I Na are similar between jugular and nodose neurons. In both cell types, the activation for TTX-S I Na begins at around -65 mV and peaks around -30 mV; the main TTX-R component activates and peaks at voltages 10-15 mV more positive than those of TTX-S, which is consistent with previously described properties of Na V 1.7-mediated TTX-S I Na and Na V 1.8-mediated TTX-R I Na (Vijayaragavan et al. 2001) . A much smaller (approximately two-fold smaller, Fig. 6B ) component of TTX-R I Na observed at more negative voltage range under the present experimental conditions is also visible in nodose cells and may be mediated by Na V 1.9 as reported previously (Coste et al. 2004) . The current density of Na V 1.8-mediated TTX-R was two-fold greater in jugular neurons (Fig. 6B) . Indeed, the G max of TTX-R channels is significantly higher in jugular neurons than in nodose cells, whereas the G max of TTX-S channels is not different in the two types of cells (Fig. 6C) . These results indicate that, in the presence of TTX, a larger amount of I Na is available to be activated at depolarized potentials in jugular neurons.
To determine whether the different TTX-R current density observed in nodose vs. jugular neurons is the result of differences in channel regulation, we examined the voltage dependence of steady-state activation and inactivation of TTX-R I Na in both cell types (n = 6 each group). As shown in Table 2 , the half-activation and half-inactivation voltages of TTX-R I Na in nodose and jugular neurons were the same, whereas the G max in jugular neurons was again higher than in nodose neurons (Table 2 ). These results suggest that the higher TTX-R current density observed in jugular neurons may be the result of a higher number of functional Na V 1.8 channels.
To determine whether the increased TTX-R current density observed in jugular neurons plays a role in maintaining the cellular excitability after the TTXsensitive I Na is eliminated, we measured the minimal amount of current required to evoke an AP in nodose and jugular neurons in the absence and presence of 1 μM TTX ( Table 3 ). TTX decreased the excitability of both nodose and jugular neurons, leading to an increase in the amount of current required to elicit an AP (Table 3) ; the inhibitory effect of TTX effect, however, was substantively greater in the nodose vs. jugular neurons (ten-fold vs. four-fold increase in current, P < 0.01, unpaired t test) ( Table 3) .
Discussion
The data obtained in the present study support two major conclusions regarding voltage-gated sodium channels and vagal nociceptors in the respiratory tract. First, AP generation in nodose Aδ-fibres and nodose C-fibres terminating in the trachea and lungs, respectively, as well as the conduction of the APs along their fibres in the vagus nerve, is strongly dependent on the activity of Na V 1.7 channels. Second, the generation of APs in the jugular C-fibre nociceptors terminating in the trachea or lungs is not strictly dependent on Na V 1.7 or other TTX-sensitive channels, although the conduction of the AP in the majority of their fibres in the vagus nerve is prevented by blocking TTX-sensitive channels (most probably Na V 1.7 and possibly Na V 1.6). The results from studies on jugular C-fibres presents a caveat when inferring data about Na V 1 subtype involvement at the nerve terminations within tissues from studies of APs conducted along the nerve trunk or in the neuronal cell bodies. TTX applied only to the tracheal compartment abolished the citric acid-induced AP discharge in capsaicin-insensitive nodose Aδ-fibres (cough receptors). This was probably a result of blockade of Na V 1.7. This conclusion is based on the finding that, in many cases, Na V 1.7 was the only TTX-sensitive Na V 1 subunit expressed in the TRPV1-negative nodose neurons retrogradely labelled from the trachea (putative nodose Aδ-fibre neurons). In addition, the selective Na V 1.7 blocker, Compound 13, which we previously characterized in guinea pig airway parasympathetic nerves (Kocmalova et al. 2017) , also abolished the response to citric acid in tracheal nodose Aδ-fibres.
When TTX was applied selectively to the tracheal compartment, it had little effect on citric acid-induced AP discharge in capsaicin-sensitive jugular C-fibres. Moreover, TTX only modestly increased the electrical stimulus voltage threshold for AP genesis in the tissue. This lack of effect of TTX was probably not the result of insufficient TTX access to the jugular C-fibres in the tissue. The jugular C-fibre terminals are often found situated more superficially (closer to the lumen) than the nodose Aδ-fibre terminals (Fig. 1C) (Hunter & Undem, 1999) and are readily influenced by acid, bradykinin, capsaicin, lidocaine and other drugs applied to the lumen (Riccio et al. 1996a; Kajekar et al. 1999; Kollarik & Undem, 2002) .
We addressed the question of whether the difference in TTX sensitivity was a result of distinctions in ganglionic origin (i.e. the placodes-derived nodose neurons vs. the neural crest-derived jugular neurons) (Baker & Bronner-Fraser, 2001 ) or a difference in nerve phenotype; tracheal nodose fibres were Aδ-fibres, whereas the jugular fibres were unmyelinated C-fibres (Riccio et al. 1996a) . We took advantage of the fact that both nodose and jugular neurons project C-fibres that terminated in the intrapulmonary compartment . Because the bradykinin-induced response in nodose C-fibres was completely abolished by selectively applying TTX to the intrapulmonary compartment (Fig. 4B) , whereas the same treatment had no effect on the intrapulmonary jugular C-fibres, it would appear that the distinction is a consequence more of the ganglionic origin of the neuron than the afferent fibre phenotype (Aδ-fibre vs. C-fibre). As with the nodose Aδ-fibre in the trachea, the TTX-sensitivity of the nodose C-fibres in the lungs is probably a result of the blockade of Na V 1.7 channels. This is supported by two selective Na V 1.7 blockers, Compound 13 and PF-05089771 (Alexandrou et al. 2016; Kocmalova et al. 2017) , mimicking TTX (Fig. 4B) .
It was not surprising that blocking Na V 1.7 also almost completely (>95%) blocked the conduction of AP in the nodose nerve fibres within the vagus. This is consistent with our previous finding where TTX or selectively blocking Na V 1.7 gene expression using AAV-shRNA technology effectively blocked AP conduction of nodose A-and C-fibres (Muroi et al. 2011) . It was more interesting to note that the conduction of APs along the jugular C-fibre in the vagus was also, in most cases (70%; 12/17 jugular C-fibres), abolished by TTX (Fig. 5 ). This reflected a stark distinction between the Na V 1 subtypes required in jugular C-fibres for the genesis of APs within the tissue (TTX-insensitive) vs. their conduction in the vagus nerve (TTX-sensitive). This is the not the first time such an observation has been made. In elegant studies carried out on trigeminal C-fibres terminating in the cornea, it was similarly found that the spike occurring at or near the nerve terminals was TTX-resistant (but blocked by lidocaine), whereas the conduction of the AP to the CNS could be abolished by TTX (Brock et al. 1998) .
Na V 1.8 channels probably play a dominant role in the induction of APs in jugular C-fibres. We found PF-01247324 (Payne et al. 2015) to be an effective but not very potent inhibitor of the putative Na V 1.8 current in guinea pig vagal sensory neurons (Fig. 4D) . At a concentration that inhibited this current by ß75%, the bradykinin-induced AP discharge in jugular C-fibres was inhibited by an average of ß50% (range of 5-95% inhibition) (Fig. 4C) . In those neurons where the response was only partially inhibited by PF-01247324, it would appear that it is the result of a redundant effect of TTX-sensitive and Na V 1.8 channels because adding TTX to PF-01247324 led to the near abolition of the response (Fig. 4C) .
The single neuron RT-PCR analysis indicates that most airway specific nodose and jugular neurons expressed Na V 1.7 and Na V 1.8 (and some neurons expressed Na V 1.6 as well). Moreover, the data obtained from whole cell patch clamp studies show that either Na V 1.7 or Na V 1.8 is sufficient to support AP genesis at the cell soma (Kwong et al. 2008) . The data also indicate that the density of Na V 1.8 in the jugular C-fibres within the tissue is sufficient to support acid-or bradykinin-induced AP genesis, although this is not the case for nodose C-fibres and nodose Aδ-fibre. This may be the result of a greater overall density of Na V 1.8 channels relative to other Na V 1 channels in the membranes of the neural crest-derived jugular neurons compared to the epibrachial placode-derived nodose neurons. Consistent with this is the observation that, with respect to current densities at the cell soma, the Na V 1.8 to Na V 1.7 ratio is significantly larger in jugular neurons than nodose neurons (Fig. 6C) . After TTX, the current needed to evoke an AP was similar between nodose and jugular neurons, although TTX had a much greater net effect (ten-fold vs. four-fold) on excitability because the nodose neurons were more excitable at baseline than jugular neurons. This is also consistent with a recent RNAseq analysis of vagal C-fibre neurons in the mouse where the Na V 1.8 expression is quantitatively greater in capsaicin-sensitive jugular neurons compared to capsaicin-sensitive nodose neurons (Wang et al. 2017) .
The results of the present study have practical implications in the use of Na V 1 blockers as therapeutic drugs. We have previously shown that Na V 1.7 blocking drugs can effectively abolish bronchoconstriction as a result of activation of vagal post-ganglionic cholinergic nerves in human and guinea pig airways (but not mouse airways) (Kocmalova et al. 2017) . In addition, in previous studies and in the present study, we have found that blocking Na V 1.7 blocked AP conduction in the vagus nerves and inhibited cough reflexes (Muroi et al. 2011 (Muroi et al. , 2013 . It might be surmised that drugs blocking the neuronal communication between the respiratory tract and brain will inhibit not only cough, but also possibly vagal reflex bronchospasm and mucus secretion, as well as dyspnoeic sensations. If the Na V 1.7 blocker drug were to be delivered via aerosol, however, the present findings indicate that it may effectively inhibit sensations and reflexes secondary to activation of respiratory nodose afferent nociceptors but not jugular nociceptors. There are at least two caveats when drawing therapeutic implications from the present study: first, there may be distinctions between human and guinea pig vagal sensory nerves with respect to Na V 1 function; second, all studies were carried in healthy animals, and Na V 1 subtype expression and function may change in the face of tissue inflammation associated with airway pathology (Chahine & O'Leary, 2014) .
